USE OF SRRD IN THE INHIBITION OF PROTEIN AGGREGATION

USE OF SRRD IN THE INHIBITION OF PROTEIN AGGREGATION

The present disclosure is directed to the use of SRR1 domain-containing protein (SRRD) or active fragment thereof to reduce protein aggregation, such as that occurring in neurodegenerative diseases. La présente invention concerne l'utilisation de la protéine contenant le domaine SRR1 (SRRD) ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SWEENEY, Katelyn, SHALEM, Ophir
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure is directed to the use of SRR1 domain-containing protein (SRRD) or active fragment thereof to reduce protein aggregation, such as that occurring in neurodegenerative diseases. La présente invention concerne l'utilisation de la protéine contenant le domaine SRR1 (SRRD) ou d'un fragment actif de celle-ci pour réduire l'agrégation protéique, telle que celle qui se produit dans des maladies neurodégénératives.